Scott W. Morrison - 09 Sep 2021 Form 4 Insider Report for Corvus Pharmaceuticals, Inc. (CRVS)

Role
Director
Signature
/s/ Leiv Lea, as Attorney-in-Fact for Scott W. Morrison
Issuer symbol
CRVS
Transactions as of
09 Sep 2021
Net transactions value
$0
Form type
4
Filing time
13 Sep 2021, 16:51:22 UTC
Previous filing
21 Jun 2021
Next filing
18 Oct 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CRVS Stock Option (Right to Buy) Award $0 +15,000 $0.000000 15,000 09 Sep 2021 Common Stock 15,000 $2.60 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The underlying shares subject to the option vest and become exercisable as to 100% of the total number of shares subject to the option on the first anniversary of the grant date.